Feed Probiotics use can secrete antibacterial substances, inhibit the reproduction of harmful bacteria in the intestine, and prevent diseases. Probiotics for animals are mainly divided into lactic acid bacteria, yeast and bacillus, etc., which are often used in the breeding process. Probiotics for veterinary use can also promote the absorption and transformation of nutrients, improve the utilization of nutrients in feed, stimulate the growth of tissue mucosa, improve immunity, and reduce the occurrence of weather changes, vaccinations and other stress reactions
We are manufacturer of Feed Probiotics in China, provide Feed Probiotics,Feed Grade Probiotics,Feed Probiotics For Poultry,Feed Additives Mixed Probiotics,like Bacillus Licheniformis,Enterococcus Faecalis,Bacillus subtilis,Bacillus coagulans,Pediococcus acidilactici,Lactobacillus acidophilus,Lactobacillus Plantarum if you want to buy Feed Grade Probiotics,Feed Probiotics For Poultry,Feed Additives Mixed Probiotics please contact us.
Feed Probiotics,Animal Feed Probiotics,Feed Probiotics For Poultry,Feed Additives Mixed Probiotics,best natural probiotics for dogs NANYANG CHENGPENG PHARMACEUTICAL CO.,LTD , https://www.chppharm.com
British “mobile nurse†helps monitor patients' condition
On November 26, 2008, t+Medical, a UK-based company, introduced an innovative mobile phone software designed to monitor the health of patients with chronic conditions in real time. This groundbreaking tool is expected to significantly reduce healthcare costs while improving patient outcomes.
The software can be easily installed on standard mobile phones, making it accessible to a wide range of users. Patients suffering from conditions such as asthma, diabetes, and hypertension can input their symptoms and treatment details directly into the app. The data is then automatically sent to a hospital database, where nurses analyze the information to determine if any medical intervention is needed. By tracking changes in a patient’s condition early, the system helps prevent complications before they become severe, reducing the need for frequent hospital visits.
A separate version of the software is specifically designed to monitor the side effects of chemotherapy. Doctors can use this data to adjust treatment plans accordingly, ensuring more personalized and effective care. So far, eight healthcare institutions across the UK have adopted this technology, showing its growing acceptance and potential impact.
According to Lionel Tara Senko, a professor at Oxford University and a member of t+Medical's board, chronic patients make up the largest portion of the national healthcare system, accounting for 80% of all outpatient services. By reducing the number of unnecessary consultations—up to 90% of which are related to long-term care—this software could save millions of pounds annually for the NHS.
This advancement highlights the power of digital health solutions in transforming traditional medical practices, offering both cost savings and improved quality of care for patients.